Ispire Technology Inc (ISPR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ...

GuruFocus News

Tue, May 13, 2025, 1:03 AM 5 min read

Revenue: $26.2 million for Q3 fiscal 2025, down from $30 million in Q3 fiscal 2024.
European Revenue: $13.2 million, a decline of 2.9% from $13.6 million in the previous year.
North America Revenue: $8.8 million, a decline of 28.9% from $12.4 million in the previous year.
Asia Pacific Revenue: $3 million, a decline of 21.4% from $3.8 million in the previous year.
Gross Profit: $4.8 million for Q3 fiscal 2025, down from $6.1 million in Q3 fiscal 2024.
Gross Margin: 18.2% for Q3 fiscal 2025, down from 20.4% in the previous year.
Operating Expenses: $15.4 million for Q3 fiscal 2025, up from $11.8 million in the previous year.
Net Loss: $10.9 million or $0.19 per share for Q3 fiscal 2025, compared to a net loss of $5.9 million or $0.11 per share in the previous year.
Cash and Cash Equivalents: $23.5 million as of March 31, 2025, a reduction of $10.9 million from the previous quarter.
Accounts Receivable: Reduced by approximately $7.3 million to $60.4 million.
Net Cash Flow from Operating Activities: Used $12.1 million for the nine months ended March 31, 2025.

Warning! GuruFocus has detected 4 Warning Signs with ISPR.

Release Date: May 12, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Ispire Technology Inc (NASDAQ:ISPR) successfully reduced its accounts receivable by approximately $7.3 million, demonstrating improved financial management.
The company secured an interim nicotine product manufacturing license in Malaysia, expanding its manufacturing capabilities and reducing geopolitical risks.
Ispire Technology Inc (NASDAQ:ISPR) filed a PMPA for its blockchain-based age gating system with the FDA, positioning itself as an innovator in regulatory compliance.
The company launched the 'Spout' cannabis vapor device, highlighting its commitment to product innovation and consumer safety.
Ispire Technology Inc (NASDAQ:ISPR) is transitioning its pricing strategy to FOB factory pricing, enhancing flexibility and market position amidst tariff challenges.

Negative Points

Total revenue for the third quarter of fiscal 2025 decreased by 12.7% compared to the same period last year, indicating a decline in sales.
Revenues from North America fell by 28.9%, largely due to new tariffs on Chinese-made products and a shift in manufacturing activities.
Operating expenses increased significantly to $15.4 million in Q3 2025 from $11.8 million in the same period last year, impacting profitability.
The company reported a net loss of $10.9 million for the third fiscal quarter of 2025, compared to a net loss of $5.9 million in the previous year.
Ispire Technology Inc (NASDAQ:ISPR) experienced a reduction in cash and cash equivalents, with a negative working capital balance of $2.1 million as of March 31, 2025.

Q & A Highlights

Q: Can you elaborate on the impact of the FDA's focus on port shopping and its effect on the illicit vape supply in the US? Do you expect a significant reduction in illicit product flow, and how does this affect your growth outlook in North America? A: Michael Wang, Co-CEO, explained that the approval of their technology could convert many consumers from using black market vaping products to more compliant and safer options. The black market for vaping products is estimated to be significantly larger than the legal market. While they don't plan to sell products in the US until FDA approval, there are opportunities outside the US where the technology could be deployed faster.

Q: Regarding the EU and the disposable vape bans, are there specific countries you're targeting, and are there any supply constraints before expanding your product offering overseas? A: Michael Wang noted that the UK and EU are moving towards banning disposables, which will shift the market to pod systems and open systems. Ispire's brand is strong in Europe, and they expect to benefit from this shift. They are confident in their manufacturing capabilities, with plans to expand production lines in Malaysia to support increased demand.

Q: How are customers in the US reacting to your new cannabis hardware devices, and what alternatives do they have given the tariff situation? A: Michael Wang highlighted the launch of the Volt platform and the [spout] product, which set new standards for safety and performance in the industry. Regarding tariffs, they have renegotiated contracts with US customers to FOB factory pricing, and plan to move most cannabis hardware production to Malaysia to mitigate tariff impacts.

Q: Do you have more flexibility than competitors due to your Malaysian facility, or are they also diversifying their supply chains? A: Michael Wang stated that while some competitors are setting up in countries like Indonesia and Vietnam, Malaysia offers a tariff advantage. They believe Malaysia will continue to have an edge over other Asian countries in terms of tariff rates.

Q: Can you discuss the financial impact of the transition to FOB factory pricing and the shift in manufacturing to Malaysia? A: James McCormick, CFO, explained that the transition to FOB factory pricing is part of their strategy to enhance flexibility and market position. The shift to Malaysia is expected to lower costs despite initial higher production costs, as it offsets tariff differences and supports long-term profitability.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

Terms and Privacy Policy

Your Privacy Choices

Utah Privacy Notice

More Info